MyAverix Finance
HK · Healthcare
Jiangsu Hengrui Pharma Co Ltd (1276)
Drug Manufacturers - Specialty & Generic
Jiangsu Hengrui Pharma Co Ltd (1276) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $414.16B, P/E ratio is 44.57, net margin is 24.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1276
Jiangsu Hengrui Pharma Co Ltd (1276) — FAQ
What is Jiangsu Hengrui Pharma Co Ltd's market cap?
Jiangsu Hengrui Pharma Co Ltd (1276) has a reported market cap of $414.16B (data as of 2026-05-21).
What is 1276's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Hengrui Pharma Co Ltd (1276) is 44.57 (data as of 2026-05-21).
Does Jiangsu Hengrui Pharma Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Hengrui Pharma Co Ltd (1276). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Hengrui Pharma Co Ltd in?
Jiangsu Hengrui Pharma Co Ltd (1276) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 1276 listed on?
1276 is listed on HK.
What is Jiangsu Hengrui Pharma Co Ltd's net margin?
Jiangsu Hengrui Pharma Co Ltd (1276) reports a net margin of 24.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.